Jan Christop L. Merene

Array ( [id] => 5409564 [patent_doc_number] => 20090123462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'FGFR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/258028 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4710 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123462.pdf [firstpage_image] =>[orig_patent_app_number] => 12258028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410038 [patent_doc_number] => 20090123937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Methods of selecting epidermal growth factor receptor (EGFR) binding agents' [patent_app_type] => utility [patent_app_number] => 12/288341 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15248 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123937.pdf [firstpage_image] =>[orig_patent_app_number] => 12288341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575914 [patent_doc_number] => 20090143276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Trimeric IL-1Ra' [patent_app_type] => utility [patent_app_number] => 12/247897 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16122 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143276.pdf [firstpage_image] =>[orig_patent_app_number] => 12247897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6264792 [patent_doc_number] => 20100297638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MOLECULAR ADAPTORS' [patent_app_type] => utility [patent_app_number] => 12/681643 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297638.pdf [firstpage_image] =>[orig_patent_app_number] => 12681643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392152 [patent_doc_number] => 20090209465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'MCT1 Transporters Expressed in Blood Brain Barrier Cells' [patent_app_type] => utility [patent_app_number] => 12/246381 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17254 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209465.pdf [firstpage_image] =>[orig_patent_app_number] => 12246381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409581 [patent_doc_number] => 20090123479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'IMMUNOGLOBULINS' [patent_app_type] => utility [patent_app_number] => 12/245426 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18502 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123479.pdf [firstpage_image] =>[orig_patent_app_number] => 12245426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639289 [patent_doc_number] => 08017316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Methods and compositions for the identification of insect repellent compounds' [patent_app_type] => utility [patent_app_number] => 12/283670 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 24 [patent_no_of_words] => 14178 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017316.pdf [firstpage_image] =>[orig_patent_app_number] => 12283670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440966 [patent_doc_number] => 20090092605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Compositions and methods for the treatment of immune related diseases' [patent_app_type] => utility [patent_app_number] => 12/283635 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 770 [patent_figures_cnt] => 770 [patent_no_of_words] => 61201 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12283635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545253 [patent_doc_number] => 08053224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Glucose-induced inactivation/degradation-resistant transporter gene and use thereof' [patent_app_type] => utility [patent_app_number] => 12/442121 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 8680 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053224.pdf [firstpage_image] =>[orig_patent_app_number] => 12442121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6563905 [patent_doc_number] => 20100272855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'HYBRID ALPHA-GLUCOSIDE TRANSPORTER' [patent_app_type] => utility [patent_app_number] => 12/442131 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11792 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272855.pdf [firstpage_image] =>[orig_patent_app_number] => 12442131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506984 [patent_doc_number] => 20100210562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'USE OF IL-1 RECEPTOR PEPTIDE, ALONE OR IN COMBINATION WITH D-ALA-GLN-OCTADECYL ESTER, AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677295 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37471 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210562.pdf [firstpage_image] =>[orig_patent_app_number] => 12677295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519969 [patent_doc_number] => 20100261881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/676223 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4260 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261881.pdf [firstpage_image] =>[orig_patent_app_number] => 12676223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323529 [patent_doc_number] => 20090061519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'METABOLIC REGULATORS' [patent_app_type] => utility [patent_app_number] => 12/200060 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23634 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061519.pdf [firstpage_image] =>[orig_patent_app_number] => 12200060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575919 [patent_doc_number] => 20090143281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'THROMBOMODULIN ANALOGS FOR USE IN RECOVERY OF SPINAL CORD INJURY' [patent_app_type] => utility [patent_app_number] => 12/197031 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6313 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143281.pdf [firstpage_image] =>[orig_patent_app_number] => 12197031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508522 [patent_doc_number] => 20090081729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Compositions and Methods Comprising a Ligand of ChemerinR' [patent_app_type] => utility [patent_app_number] => 12/184783 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 33022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081729.pdf [firstpage_image] =>[orig_patent_app_number] => 12184783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112570 [patent_doc_number] => 08568737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Screening methods using G-protein coupled receptors and related compositions' [patent_app_type] => utility [patent_app_number] => 12/671429 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 44 [patent_no_of_words] => 32458 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585442 [patent_doc_number] => 20090104644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'GENETICALLY MODIFIED CYCLIC-NUCLEOTIDE CONTROLLED ION CHAN' [patent_app_type] => utility [patent_app_number] => 12/182395 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11523 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104644.pdf [firstpage_image] =>[orig_patent_app_number] => 12182395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11320252 [patent_doc_number] => 09518992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-13 [patent_title] => 'Kits for the diagnosis of pre-eclampsia or eclampsia' [patent_app_type] => utility [patent_app_number] => 12/220245 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 30991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12220245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452151 [patent_doc_number] => 20090068188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'C-C chemokine receptor 3 proteins' [patent_app_type] => utility [patent_app_number] => 12/218102 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 37361 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068188.pdf [firstpage_image] =>[orig_patent_app_number] => 12218102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452159 [patent_doc_number] => 20090068196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Pharmaceutical formulation of an antibody against IL13Ralpha1' [patent_app_type] => utility [patent_app_number] => 12/217942 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5660 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068196.pdf [firstpage_image] =>[orig_patent_app_number] => 12217942 [rel_patent_id] =>[rel_patent_doc_number] =>)